| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (673kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-521134
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.52113
Zusammenfassung
Introduction: Detection of disseminated cancer cells (DCC) in bone marrow (BM) of patients with early-stage NSCLC has been associated with poor outcome. However, the phenotype, and hence relevant therapy targets, of DCCs in BM are unknown. We therefore compared a classical pan-Cytokeratin (CK) antibody for DCC detection with an anti-EpCAM antibody that may also detect more stem-like cells and ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik